canin
parvoviru
infect
occur
worldwid
domest
dog
wild
canid
incid
higher
anim
shelter
pet
store
breed
kennel
although
affect
breed
dog
age
sever
infect
common
puppi
week
month
old
hueffer
et
al
diseas
condit
complic
due
emerg
number
variant
name
year
involv
domest
wild
canin
buonavoglia
et
al
martella
et
al
absenc
suitabl
antivir
therapi
protect
dog
cpv
infect
support
treatment
option
reduc
mortal
due
diseas
therapeut
efficaci
recombin
felin
interferon
recombin
canin
granulocyt
factor
evalu
cpv
limit
like
commerci
nonavail
place
exorbit
price
make
therapeut
regular
use
de
mari
maynard
eun
lebreux
duffi
dow
ogilvi
rao
hackett
mylonaki
kalli
ralli
oseltamivir
neuraminidas
inhibitor
also
tri
treatment
cpv
without
substanti
benefit
term
surviv
durat
hospit
savigni
macintir
recent
year
oxid
stress
paid
much
attent
due
pivot
role
pathogenesi
viral
diseas
beck
handi
levand
schwarz
dermodi
oxid
stress
occur
due
imbal
product
reactiv
oxygennitrogen
speci
neutral
antioxid
enzym
kim
kim
hahm
lykkesfeldt
svendsen
free
oxid
stress
caus
oxid
polyunsatur
fatti
acid
erythrocyt
cell
membran
result
lipid
peroxid
malondialdehyd
mda
princip
studi
product
polyunsatur
fatti
acid
peroxid
classic
marker
free
cell
damag
del
rio
stewart
pellegrini
kuhn
borchert
determin
mda
plasma
indic
degre
lipid
peroxid
concentr
free
oxygen
radic
indirectli
deger
deger
bicek
ozdal
gul
nitric
oxid
anoth
essenti
messeng
molecul
physiolog
concentr
becom
free
radic
gener
peroxynitrit
anion
onoo
excess
consid
marker
oxid
stress
pacher
beckman
liaudet
pierini
bryan
glutathion
gst
metabol
isozym
play
crucial
role
defens
mechan
oxid
injuri
et
al
gst
protect
cell
oxid
stress
detoxifi
secondari
reactiv
oxygen
speci
ro
produc
ro
react
cellular
constitu
veal
toonem
jone
morgan
oxidantantioxid
imbal
report
pathogenesi
enter
viral
diseas
like
felin
coronaviru
bovin
porcin
reproduct
respiratori
syndrom
rotaviru
de
et
al
durgut
ataseven
kayar
et
al
stukelj
toplak
nemec
svete
recent
observ
parvoviru
infect
link
oxid
stress
mark
enhanc
reactiv
oxygennitrogen
speci
lipid
peroxid
dna
damag
poor
antioxid
reserv
luo
qiu
nykki
vuento
gilbert
panda
patra
nandi
swarup
recent
year
emphasi
given
antioxid
potenti
drug
interest
manag
viral
diseas
beck
chandrasena
et
al
crump
langston
rajkarnikar
grayson
strong
associ
cpv
oxid
stress
suggest
incorpor
antioxid
therapeut
regimen
canin
parvovir
diarrhea
may
help
amelior
clinic
sign
nac
bodi
primari
cellular
antioxid
precursor
glutathion
role
glutathion
mainten
metabol
well
establish
kelli
glutathion
counteract
harm
effect
reactiv
oxygen
nitrogen
speci
direct
indirect
scaveng
dean
giorlando
berk
antioxid
efficaci
nac
evalu
hepat
cholangiohepat
dog
noninfecti
system
diseas
condit
rat
dean
et
al
ribeiro
et
al
sadowska
de
backer
seguro
poli
de
figueiredo
shimizu
shahripour
harrigan
alexandrov
stanislau
gilg
singh
singh
webster
cooper
recent
antioxid
effect
nac
report
viral
diseas
includ
hiv
influenza
geiler
et
al
sgarbanti
et
al
staal
uchid
toyoda
howev
antioxid
effect
nac
dog
natur
affect
parvovir
diarrhea
yet
explor
therefor
studi
aim
evalu
antioxid
potenti
nac
diarrheic
dog
infect
canin
parvoviru
studi
conduct
referr
veterinari
polyclin
teach
veterinari
clinic
complex
institut
februari
may
total
dog
age
group
month
complain
pyrexia
weak
reduc
appetit
sever
dehydr
hemorrhag
diarrhea
vomit
taken
studi
dog
unvaccin
fecal
sampl
clinic
case
collect
diseas
diagnosi
conduct
studi
fecal
sampl
found
posit
parvoviru
infect
polymeras
chain
reaction
dog
randomli
pick
divid
equal
two
treatment
group
group
consist
nine
canin
gastroenter
case
nine
dog
group
b
receiv
support
treatment
st
consist
intraven
fluid
antibiot
antiemet
well
drug
meloxicam
indic
wherea
nine
dog
group
c
receiv
st
plu
nac
mgkg
bodi
weight
daili
intraven
rout
consecut
day
nine
healthi
dog
similar
age
group
recruit
studi
present
either
routin
health
check
vaccin
serv
control
group
dog
examin
treat
expert
clinician
studi
conduct
per
guidelin
institut
anim
ethic
committe
care
anim
undertaken
per
guidelin
committe
purpos
control
supervis
experi
anim
india
fecal
sampl
collect
diarrheic
dog
episod
hemorrhag
gastroenter
viru
transport
media
dulbecco
modifi
eagl
medium
fetal
bovin
serum
mgl
gentamycin
sampl
centrifug
g
min
centrifug
supernat
separ
stool
sampl
eppendorf
tube
tri
satur
phenol
ad
mix
well
centrifug
g
min
total
volum
phenol
ad
supernat
mix
well
centrifug
supernat
collect
chloroform
ad
centrifug
total
volum
supernat
collect
separ
tube
sodium
acet
ml
absolut
ethanol
ad
mix
tube
kept
overnight
next
day
tube
centrifug
g
min
supernat
discard
ethanol
ad
repeat
centrifug
process
supernat
discard
pellet
dri
final
dissolv
water
gene
cpv
use
diagnosi
studi
pereira
monezi
mehnert
dangelo
durigon
forward
gaa
gag
tgg
ttg
taa
ata
ata
revers
cct
ata
tca
cca
aag
tta
gta
g
primer
set
imperi
biomed
use
amplifi
part
gene
cpv
yield
product
bp
pereira
et
al
pcr
pcr
mastermix
forward
revers
primer
pmol
extract
dna
templat
rest
water
nfw
make
final
volum
suitabl
templat
control
nfw
instead
templat
dna
includ
neg
control
wherea
cpv
isol
laboratori
amplifi
pcr
clone
clone
vector
sequenc
taken
posit
control
pcr
perform
thermal
cycler
appli
biosystem
usa
cyclic
condit
denatur
primer
anneal
extens
cyclic
condit
repeat
time
final
extens
given
min
pcr
amplifi
product
analyz
agaros
gel
contain
ethidium
bromid
final
concentr
ten
microlit
amplifi
product
mix
bromophenol
dye
load
well
run
along
bp
kbp
dna
ladder
tae
electrophoresi
buffer
progress
mobil
monitor
migrat
dye
end
electrophoresi
gel
visual
uv
transillumi
nandi
pandey
sharma
chauhan
pcr
product
gel
elut
clone
use
clone
jet
pcr
clone
kit
sequenc
substanti
authent
result
blood
sampl
approxim
ml
collect
venipunctur
either
cephal
recurr
tarsal
vein
vial
particip
dog
associ
routin
clinic
sampl
initi
treatment
ml
ml
blood
use
hematolog
ml
blood
immedi
centrifug
g
min
separ
plasma
store
analysi
hematolog
analysi
blood
perform
manual
jain
concentr
hemoglobin
hb
whole
blood
measur
modifi
sahil
acid
hematin
method
red
blood
cell
rbc
white
blood
cell
wbc
count
measur
neubauer
hemocytomet
methanol
fix
blood
smear
stain
dilut
giemsa
stain
min
differenti
leukocyt
count
dlc
done
hematolog
perform
treatment
day
thereaft
day
initi
treatment
lipid
peroxid
measur
determin
plasma
malondialdehyd
mda
concentr
doubl
heat
method
draper
hadley
short
ml
triochloroacet
acid
tca
mix
ml
plasma
test
tube
mixtur
kept
boil
water
bath
min
reaction
mixtur
cool
centrifug
g
min
two
millilit
supernat
taken
mix
ml
tba
separ
tube
incub
boil
water
bath
min
solut
cool
room
temperatur
absorb
measur
nm
use
spectrophotomet
concentr
plasma
mda
calcul
absorb
coeffici
thiobarbitur
complex
valu
express
nmolml
nox
plasma
measur
reduct
nitrat
alloy
follow
color
develop
griess
reagent
sastri
maudgal
mohan
tyagi
rao
briefli
reaction
mixtur
consist
plasma
sampl
carbon
buffer
powder
alloy
incub
hr
room
temperatur
frequent
shake
reaction
stop
addit
naoh
vortex
reaction
mixtur
centrifug
g
min
supernat
separ
ad
griess
reagent
naphthalen
diamin
dihydrochlorid
n
hydrochlor
acid
sulfanilamid
ratio
micropl
optic
densiti
read
nm
micropl
reader
incub
min
room
temperatur
valu
nox
product
calcul
standard
curv
use
differ
concentr
potassium
nitrat
plasma
gst
activ
assay
use
commerci
avail
kit
ezassaytm
gst
activ
estim
kit
product
code
himedia
mumbai
india
valu
express
data
analyz
use
statist
softwar
packag
sa
v
sa
institut
inc
cari
nc
usa
determin
whether
averag
tlc
neutrophil
lymphocyt
monocyt
eosinophil
basophil
count
mda
nox
concentr
gst
activ
significantli
differ
dog
compar
control
dog
time
data
taken
repeatedli
differ
time
interv
dog
analyz
use
repeat
measur
model
dog
subject
period
repeat
measur
anova
use
compar
treatment
hematolog
oxid
stress
indic
test
interact
found
tukey
post
hoc
test
use
determin
statist
signific
differ
treatment
group
individu
dog
consid
experiment
unit
probabl
level
p
select
statist
select
limit
test
interact
present
treatment
hematolog
oxid
stress
indic
determin
anova
obtain
tukey
post
hoc
test
relev
treatment
group
present
interact
present
obtain
anova
present
result
express
mean
sem
clinic
examin
canin
parvoviru
affect
dog
exhibit
clinic
sign
high
rise
temperatur
weak
reduc
appetit
sever
dehydr
bloodi
diarrhea
vomit
affect
dog
dog
found
posit
cpv
infect
pcr
use
primer
process
fecal
sampl
evid
presenc
expect
bp
dna
product
agaros
gel
uv
transillumin
rest
eight
sampl
found
neg
cpv
infect
pcr
specif
band
visual
figur
mean
hb
concentr
rbc
count
significantli
higher
p
dog
group
b
group
c
compar
control
dog
group
treatment
support
treatment
support
treatment
plu
nac
significantli
p
improv
hb
concentr
rbc
count
dog
day
compar
pretreat
valu
statist
signific
interact
found
treatment
hb
p
rbc
count
p
figur
mark
leucopenia
neutropenia
p
observ
dog
compar
healthi
dog
mean
wbc
neutrophil
count
differ
significantli
time
dog
receiv
st
wbc
count
day
neutrophil
count
day
improv
significantli
follow
treatment
p
reach
closer
valu
healthi
dog
group
wbc
count
compar
dog
group
b
c
control
dog
group
found
count
significantli
higher
day
dog
dog
valu
differ
significantli
compar
control
dog
similarli
mean
neutrophil
count
dog
appreci
improv
treatment
group
c
day
p
follow
st
group
b
howev
statist
signific
interact
note
treatment
wbc
count
p
neutrophil
count
p
tabl
mark
reduct
averag
monocyt
eosinophil
count
infect
dog
group
b
c
compar
healthi
dog
group
conspicu
improv
averag
monocyt
eosinophil
count
day
day
dog
receiv
st
group
b
howev
dog
group
c
show
better
result
p
term
monocyt
eosinophil
count
day
mean
monocyt
eosinophil
count
compar
dog
control
dog
signific
differ
notic
day
mean
lymphocyt
basophil
count
remain
unaffect
throughout
studi
period
treat
group
statist
signific
interact
found
treatment
monocyt
count
p
interact
present
lymphocyt
p
eosinophil
p
basophil
count
p
tabl
dog
significantli
lower
concentr
gst
p
higher
concentr
nox
p
mda
p
notic
compar
healthi
dog
although
mean
valu
gst
nox
mda
concentr
differ
significantli
throughout
studi
period
dog
receiv
st
group
b
signific
elev
mean
gst
p
concentr
appreci
reduct
nox
p
mda
p
concentr
day
dog
group
c
valu
compar
group
found
mean
gst
p
activ
significantli
increas
nox
p
mda
p
concentr
significantli
reduc
day
dog
compar
dog
statist
signific
interact
treatment
nox
concentr
p
gst
activ
p
mda
concentr
p
figur
studi
pronounc
elev
hb
rbc
count
infect
dog
indic
hemoconcentr
parvovir
diarrhea
parvovir
enter
caus
anemia
attribut
cytotox
effect
viru
hematopoiet
cell
bone
marrow
failur
subsequ
erythroid
hypoplasia
acut
stage
diseas
grime
fri
nandi
kumar
stann
digiacomo
gidden
evermann
contrast
hemoconcentr
studi
might
due
excess
fluid
loss
episod
diarrhea
furthermor
leucopenia
neutropenia
major
hemogram
alter
dog
castro
et
al
leukopenia
neutropenia
dog
could
due
destruct
hematopoiet
progenitor
cell
variou
leukocyt
type
bone
marrow
inadequ
suppli
massiv
demand
leukocyt
inflam
gastrointestin
tract
loss
neutrophil
damag
gastrointestin
tract
macartney
mccandlish
thompson
cornwel
fulton
et
al
goddard
leisewitz
christoph
duncan
becker
howev
wbc
count
restor
day
dog
follow
treatment
spite
progress
improv
neutrophil
count
time
neutropenia
still
persist
day
compar
control
healthi
dog
warrant
longer
durat
treatment
nac
improv
neutrophil
count
health
condit
dog
although
report
effect
nac
stimul
neutrophil
product
howev
report
nac
stimul
pluripot
stem
cell
differenti
toward
hematopoiet
cell
laboratori
anim
model
berniakovich
izpisua
belmont
goddard
et
al
opin
blood
leukocyt
count
could
prognost
indic
canin
parvovir
enter
outcom
diseas
much
learn
benefici
effect
antioxid
viral
diseas
recent
year
beck
peterhan
zhang
wang
chen
chen
tian
studi
deriv
influenza
viru
indic
posit
impact
nac
antioxid
molecul
viral
pathogenesi
casanova
garigliani
garigliani
desmecht
studi
pronounc
elev
mda
nox
drop
gst
activ
infect
dog
compar
healthi
dog
initi
therapi
indic
mark
oxid
stress
parvoviru
infect
corrobor
find
worker
luo
qiu
nykki
et
al
panda
et
al
oxid
stress
implic
sever
viral
infect
human
anim
report
oxid
stress
mediat
damag
mitochondri
membran
dna
damag
besid
liber
proinflammatori
cytokin
barzilai
yamamoto
goddard
leisewitz
nykki
et
al
support
treatment
alon
succeed
reduc
level
mda
nox
improv
gst
activ
dog
till
day
compar
pretreat
valu
day
howev
inclus
nac
support
treatment
significantli
p
reduc
mda
nox
concentr
increas
gst
activ
plasma
day
onward
initi
treatment
indic
amelior
potenti
nac
oxid
stress
cpv
diarrhea
nac
inhibit
induc
nitric
oxid
synthas
suppress
proinflammatori
cytokin
expressionreleas
reduc
lipid
peroxid
serum
restor
nonenzymat
antioxid
reserv
human
laboratori
anim
model
akca
et
al
caglikulekci
et
al
kasperczyk
et
al
ribeiro
et
al
shahripour
et
al
furthermor
nac
supplement
significantli
reduc
plasma
malondialdehyd
mda
acet
acid
aa
ulcer
coliti
rat
model
stabil
erythrocyt
glutathion
concentr
decreas
degre
lipid
peroxid
sick
dog
experi
system
oxid
stress
first
hr
hospit
kuruta
cetinkaya
bulbuloglu
viviano
wielen
recent
geiler
et
al
observ
nac
inhibit
viru
replic
proinflammatori
cytokin
chemokin
gene
express
influenza
viru
infect
benefici
effect
nac
report
highli
pathogen
influenza
viru
infect
chronic
obstruct
pulmonari
diseas
diarrhea
dekhuijzen
garigliani
desmecht
guerrero
torr
guerrero
acosta
find
studi
conclud
antioxid
like
nac
repres
potenti
addit
treatment
option
could
consid
case
parvovir
diarrhea
howev
therapeut
efficaci
nac
involv
larg
number
dog
parvoviru
infect
need
studi
extract
full
potenti
compound
comprehens
result
